Literature DB >> 18347290

X-linked ectodermal dysplasia with immunodeficiency caused by NEMO mutation: early recognition and diagnosis.

Anthony J Mancini1, Leslie P Lawley, Gulbu Uzel.   

Abstract

BACKGROUND: X-linked ectodermal dysplasia with immunodeficiency (XL-EDA-ID) is described in patients with hypomorphic mutations in IKBKG (the inhibitory kappaB kinase gamma gene), which encodes nuclear factor kappaB essential modulator (NEMO). Features include hypohidrosis, dental anomalies, alopecia, and immunodeficiency. Boys with NEMO mutations often present with serious infections, but the NEMO mutations are rarely diagnosed early in infancy. Cutaneous features in these patients are poorly elucidated. OBSERVATIONS: A 12-week-old male infant presented with a recalcitrant skin eruption, intertrigo, atopiclike dermatitis, and erythroderma. Alopecia, frontal bossing, and periorbital wrinkling were present, and family history revealed incontinentia pigmenti in his mother. Laboratory evaluation revealed leukocytosis with eosinophilia, low IgG and IgM levels, and absent IgA. Flow cytometry revealed lymphocytosis with elevated CD3(+) and CD4(+) counts and low levels of natural killer cells. Amplification and sequencing of IKBKG revealed insertion of cytosine at nucleotide 1167 (1167-1168insC) in exon 10, with frameshift mutation in the zinc-finger domain. Peripheral blood stem cell transplantation led to initial engraftment and improvement in his skin findings, but his engrafted cell counts diminished, and a second stem cell transplantation was planned.
CONCLUSIONS: Mutations in NEMO should be considered in male infants with recalcitrant seborrheic or atopic dermatitislike eruptions and intertrigo, especially when features of ectodermal dysplasia are present. Early recognition and diagnosis are desirable, prior to the onset of manifestations of immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18347290     DOI: 10.1001/archderm.144.3.342

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  14 in total

1.  Successful hematopoietic cell transplantation in patients with unique NF-κB essential modulator (NEMO) mutations.

Authors:  J K Abbott; R R Quinones; M T de la Morena; E W Gelfand
Journal:  Bone Marrow Transplant       Date:  2014-07-28       Impact factor: 5.483

2.  NEMO is a key component of NF-κB- and IRF-3-dependent TLR3-mediated immunity to herpes simplex virus.

Authors:  Magali Audry; Michael Ciancanelli; Kun Yang; Aurelie Cobat; Huey-Hsuan Chang; Vanessa Sancho-Shimizu; Lazaro Lorenzo; Tim Niehues; Janine Reichenbach; Xiao-Xia Li; Alain Israel; Laurent Abel; Jean-Laurent Casanova; Shen-Ying Zhang; Emmanuelle Jouanguy; Anne Puel
Journal:  J Allergy Clin Immunol       Date:  2011-07-01       Impact factor: 10.793

Review 3.  Genetic lessons learned from X-linked Mendelian susceptibility to mycobacterial diseases.

Authors:  Jacinta Bustamante; Capucine Picard; Stéphanie Boisson-Dupuis; Laurent Abel; Jean-Laurent Casanova
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

4.  Successful treatment with infliximab for inflammatory colitis in a patient with X-linked anhidrotic ectodermal dysplasia with immunodeficiency.

Authors:  Tomoyuki Mizukami; Megumi Obara; Ryuta Nishikomori; Tomoki Kawai; Yoshihiro Tahara; Naoki Sameshima; Kousuke Marutsuka; Hiroshi Nakase; Nobuhiro Kimura; Toshio Heike; Hiroyuki Nunoi
Journal:  J Clin Immunol       Date:  2011-10-13       Impact factor: 8.317

5.  Increased lysis of stem cells but not their differentiated cells by natural killer cells; de-differentiation or reprogramming activates NK cells.

Authors:  Han-Ching Tseng; Aida Arasteh; Avina Paranjpe; Antonia Teruel; Wendy Yang; Armin Behel; Jackelyn A Alva; Gina Walter; Christian Head; Tomo-o Ishikawa; Harvey R Herschman; Nicholas Cacalano; April D Pyle; No-Hee Park; Anahid Jewett
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

Review 6.  Common dermatologic manifestations of primary immune deficiencies.

Authors:  Manisha Relan; Heather K Lehman
Journal:  Curr Allergy Asthma Rep       Date:  2014-12       Impact factor: 4.919

Review 7.  Allogeneic hematopoietic stem cell transplantation for X-linked ectodermal dysplasia and immunodeficiency: case report and review of outcomes.

Authors:  Perdita Permaul; Anupama Narla; Jason L Hornick; Sung-Yun Pai
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

8.  Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory disease.

Authors:  Jevgenia Zilberman-Rudenko; Linda Monaco Shawver; Alex W Wessel; Yongquan Luo; Martin Pelletier; Wanxia Li Tsai; Younglang Lee; Spiridon Vonortas; Laurence Cheng; Jonathan D Ashwell; Jordan S Orange; Richard M Siegel; Eric P Hanson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-22       Impact factor: 11.205

9.  Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations.

Authors:  Charline Miot; Kohsuke Imai; Chihaya Imai; Anthony J Mancini; Zeynep Yesim Kucuk; Tokomki Kawai; Ryuta Nishikomori; Etsuro Ito; Isabelle Pellier; Sophie Dupuis Girod; Jeremie Rosain; Shinya Sasaki; Shanmuganathan Chandrakasan; Jana Pachlopnik Schmid; Tsubasa Okano; Estelle Colin; Alberto Olaya-Vargas; Marco Yamazaki-Nakashimada; Waseem Qasim; Sara Espinosa Padilla; Andrea Jones; Alfons Krol; Nyree Cole; Stephen Jolles; Jack Bleesing; Thomas Vraetz; Andrew R Gennery; Mario Abinun; Tayfun Güngör; Beatriz Costa-Carvalho; Antonio Condino-Neto; Paul Veys; Steven M Holland; Gulbu Uzel; Despina Moshous; Benedicte Neven; Stéphane Blanche; Stephan Ehl; Rainer Döffinger; Smita Y Patel; Anne Puel; Jacinta Bustamante; Erwin W Gelfand; Jean-Laurent Casanova; Jordan S Orange; Capucine Picard
Journal:  Blood       Date:  2017-07-05       Impact factor: 22.113

10.  Transplantation from a symptomatic carrier sister restores host defenses but does not prevent colitis in NEMO deficiency.

Authors:  Christian Klemann; Ulrich Pannicke; Deborah J Morris-Rosendahl; Katerina Vlantis; Marta Rizzi; Holm Uhlig; Thomas Vraetz; Carsten Speckmann; Brigitte Strahm; Manolis Pasparakis; Klaus Schwarz; Stephan Ehl; Jan C Rohr
Journal:  Clin Immunol       Date:  2016-01-23       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.